1,173 research outputs found

    Matewan Before the Massacre: Politics, Coal, and the Roots of Conflict in Mingo County, 1793-1920

    Get PDF
    On May 19, 1920, gunshots rang through the streets of Matewan, West Virginia, in an event soon known as the “Matewan Massacre.” Most historians of West Virginia and Appalachia see this event as the beginning of a long series of events known as the second mine wars. This dissertation argues that this event was, rather, the culmination of an even longer series of events that unfolded in Mingo County, dating back at least to the Civil War, and setting the stage for the second mine war. Equally important, while it is outside the scope of this dissertation, the conflicts in Mingo County’s history that crystallized around the massacre continued to resonate throughout the twentieth century while the county’s residents worked to balance their lives against the public’s knowledge of the best known events of their history, including the massacre and the earlier Hatfield-McCoy feud. This dissertation’s strength is that it provides the first comprehensive history of the area that became Mingo County in 1895, a history that begins here in the late eighteenth century and continues to the massacre. The dissertation interweaves the area’s economic history, including the development of coal mining and struggles over land ownership; labor history, including early efforts at unionization; transportation history, including the role of the N &W Railroad; political history, including the role of political factions in the county’s two major communities — Matewan and Williamson — and the impact of the state’s governors and legislatures on the county; and history of violence, including the Hatfield-McCoy feud. Equally important, this dissertation argues that the history of the southern West Virginia coalfields is far more complex than we have believed previously. Mingo County did not have the large immigrant population of its neighbors. Nor did it have the large-scale mining operations that could withstand fluctuations in the coal markets better than did the small mines in Mingo County. The dissertation draws on extensive use of county court records, local newspapers, oral history interviews, correspondence with a Matewan local historian, and the papers of coal company owners to address the question of why the massacre happened in Matewan on that date — a question that can only be answered by knowing the history of the county before that date

    Mud and Bluebells

    Get PDF
    A thesis presented to the faculty of the College of Arts and Sciences at Morehead State University in partial fulfillment of the requirements for the Degree of Master of Arts by Rebecca L. Bailey in December of 1986

    Archeota, Spring 2016

    Get PDF
    https://scholarworks.sjsu.edu/saasc_archeota/1002/thumbnail.jp

    Working with Latinx Immigrant Families in the United States: A Culturally Informed Structural Family Therapy Approach

    Get PDF
    As the Latinx population in the United States steadily grows, it is imperative that mental health practitioners grow their understanding of this population to be able to provide culturally competent services. There is a unique set of stressors faced by Latinx immigrants in the United States, especially Latinx immigrant youth. These stressors pose a disruption to Latinx immigrant family systems, leading to internalizing and externalizing symptoms. To better understand the stressors Latinx immigrants face and their impact on families, research was conducted on this population\u27s statistics, characteristics, common issues, problems, and risk factors. In addition, research was conducted on approaches for working with this population. Applicable terminology, relevant frameworks, considerations for engagement, and evidence-based practices were examined. Through this research, the necessity of recognizing families’ cultural values and their influence on the family system became apparent. This research was then used to inform the development of a six-week evidence-based treatment curriculum for working with a pseudo-Latinx immigrant family

    Which treatments provide the most relief for pharyngitis pain?

    Get PDF
    Nonsteroidal anti-inflammatory drugs (NSAIDs), acetaminophen, antibiotics, and oral and intramuscular steroids are effective (strength of recommendation [SOR]: A, meta-analysis). Ibuprofen relieves pain more effectively than acetaminophen (SOR: A, meta-analysis). Antibiotics reduce pain in confirmed bacterial infections (SOR: A, multiple randomized controlled trials [RCTs]). Steroids are superior to placebo (SOR: A, meta-analysis). Traditional demulcents, agents that help form a film over mucous membranes, provide less than 30 minutes of pain relief (SOR: B, small RCT); demulcents that contain benzocaine or lidocaine are longer acting (SOR: B, small RCT). The efficacy of herbal remedies can't be determined because of lack of high-quality studies (SOR: A, meta-analysis). Zinc doesn't reduce pharyngitis symptoms (SOR: A, meta-analysis)

    The Learning Healthcare System: How an Adult Education Lens Can Be Used to Inform a Paradigm Shift in US Healthcare Landscape

    Get PDF
    Adult education researchers and practitioners have an unprecedented opportunity to inform and learn with the health care system as it embraces learning as a process to provide the best care at lower cost

    Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.

    Get PDF
    BACKGROUND: Stroke is the major cause of adult disability. Selective serotonin reuptake inhibitors (SSRIs) have been used for many years to manage depression. Recently, small trials have demonstrated that SSRIs might improve recovery after stroke, even in people who are not depressed. Systematic reviews and meta-analyses are the least biased way to bring together data from several trials. Given the promising effect of SSRIs on stroke recovery seen in small trials, a systematic review and meta-analysis is needed. OBJECTIVES: To determine whether SSRIs improve recovery after stroke, and whether treatment with SSRIs was associated with adverse effects. SEARCH METHODS: We searched the Cochrane Stroke Group Trials Register (August 2011), Cochrane Depression Anxiety and Neurosis Group Trials Register (November 2011), Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2011, Issue 8), MEDLINE (from 1948 to August 2011), EMBASE (from 1980 to August 2011), CINAHL (from 1982 to August 2011), AMED (Allied and Complementary Medicine) (from 1985 to August 2011), PsycINFO (from 1967 to August 2011) and PsycBITE (Pyschological Database for Brain Impairment Treatment Efficacy) (March 2012). To identify further published, unpublished and ongoing trials we searched trials registers, pharmaceutical websites, reference lists, contacted experts and performed citation tracking of included studies. SELECTION CRITERIA: We included randomised controlled trials that recruited stroke survivors (ischaemic or haemorrhagic) at any time within the first year. The intervention was any SSRI, given at any dose, for any period. We excluded drugs with mixed pharmacological effects. The comparator was usual care or placebo. In order to be included, trials had to collect data on at least one of our primary (dependence and disability) or secondary (impairments, depression, anxiety, quality of life, fatigue, healthcare cost, death, adverse events and leaving the trial early) outcomes. DATA COLLECTION AND ANALYSIS: We extracted data on demographics, type of stroke, time since stroke, our primary and secondary outcomes, and sources of bias. For trials in English, two review authors independently extracted data. For Chinese papers, one review author extracted data. We used standardised mean differences (SMD) to estimate treatment effects for continuous variables, and risk ratios (RR) for dichotomous effects, with their 95% confidence intervals (CIs). MAIN RESULTS: We identified 56 completed trials of SSRI versus control, of which 52 trials (4059 participants) provided data for meta-analysis. There were statistically significant benefits of SSRI on both of the primary outcomes: RR for reducing dependency at the end of treatment was 0.81 (95% CI 0.68 to 0.97) based on one trial, and for disability score, the SMD was 0.91 (95% CI 0.60 to 1.22) (22 trials involving 1343 participants) with high heterogeneity between trials (I(2) = 87%; P < 0.0001). For neurological deficit, depression and anxiety, there were statistically significant benefits of SSRIs. For neurological deficit score, the SMD was -1.00 (95% CI -1.26 to -0.75) (29 trials involving 2011 participants) with high heterogeneity between trials (I(2) = 86%; P < 0.00001). For dichotomous depression scores, the RR was 0.43 (95% CI 0.24 to 0.77) (eight trials involving 771 participants) with high heterogeneity between trials (I(2) = 77%; P < 0.0001). For continuous depression scores, the SMD was -1.91 (95% CI -2.34 to -1.48) (39 trials involving 2728 participants) with high heterogeneity between trials (I(2) = 95%; P < 0.00001). For anxiety, the SMD was -0.77 (95% CI -1.52 to -0.02) (eight trials involving 413 participants) with high heterogeneity between trials (I(2) = 92%; P < 0.00001). There was no statistically significant benefit of SSRI on cognition, death, motor deficits and leaving the trial early. For cognition, the SMD was 0.32 (95% CI -0.23 to 0.86), (seven trials involving 425 participants) with high heterogeneity between trials (I(2) = 86%; P < 0.00001). The RR for death was 0.76 (95% CI 0.34 to 1.70) (46 trials involving 3344 participants) with no heterogeneity between trials (I(2) = 0%; P = 0.85). For motor deficits, the SMD was -0.33 (95% CI -1.22 to 0.56) (two trials involving 145 participants). The RR for leaving the trial early was 1.02 (95% CI 0.86 to 1.21) in favour of control, with no heterogeneity between trials. There was a non-significant excess of seizures (RR 2.67; 95% CI 0.61 to 11.63) (seven trials involving 444 participants), a non-significant excess of gastrointestinal side effects (RR 1.90; 95% CI 0.94 to 3.85) (14 trials involving 902 participants) and a non-significant excess of bleeding (RR 1.63; 95% CI 0.20 to 13.05) (two trials involving 249 participants) in those allocated SSRIs. Data were not available on quality of life, fatigue or healthcare costs.There was no clear evidence from subgroup analyses that one SSRI was consistently superior to another, or that time since stroke or depression at baseline had a major influence on effect sizes. Sensitivity analyses suggested that effect sizes were smaller when we excluded trials at high or unclear risk of bias.Only eight trials provided data on outcomes after treatment had been completed; the effect sizes were generally in favour of SSRIs but CIs were wide. AUTHORS' CONCLUSIONS: SSRIs appeared to improve dependence, disability, neurological impairment, anxiety and depression after stroke, but there was heterogeneity between trials and methodological limitations in a substantial proportion of the trials. Large, well-designed trials are now needed to determine whether SSRIs should be given routinely to patients with stroke
    • …
    corecore